Initiate a Phase 1/2 clinical trial for CFT7455
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 6 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initiate a Phase 1/2 clinical trial for CFT7455 in relapsed or refractory non-Hodgkin lymphomas and multiple myeloma in 1H 2021.”
What we found
Evidence strength A What the grades mean
The company initiated the Phase 1/2 clinical trial for CFT7455 in June 2021, which is within the first half of 2021.
-
A C4 Therapeutics, Inc. 10-Q filed 2021-08-11
“We initiated a first-in-human Phase 1/2 clinical trial for this product candidate in June of 2021.” ✓ confirmed on the page
Market reaction: the shares moved +6.5% against the S&P 500 over the three sessions around the disclosure (10 Aug 2021 to 13 Aug 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- Phase 1/2 clinical trial for CFT7455
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: Pending FDA clearance
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you C4 Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CCCC-021180 · Corrections policy